CTOs on the Move

Acelity

www.acelity.com

 
Acelity is a global market leader in advanced wound therapeutics and regenerative medicine, offering innovative solutions from the hospital to home that improve the lives of patients in more than 80 countries. Our mission is to change the practice of medicine with solutions that speed healing, create economic value and improve patients’ lives. We are the undisputed leader in negative pressure wound therapy, the number one provider of regenerative tissue products used for breast reconstruction and hernia repair, and the market leader in collagen dressings. Acelity is headquartered in San Antonio, Texas, with more than 5,800 employees around the globe.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.acelity.com
  • 12930 W Interstate 10
    San Antonio, TX USA 78249
  • Phone: 908.947.1215

Executives

Name Title Contact Details
Deron Means
Sr. Director Information Security and Compliance Profile

Similar Companies

FOLX Health

Welcome to FOLX, the first digital Telehealth company that gives the LGBTQIA+ community access to quality care that’s in service of our needs and in celebration of our lives.⁠

Clean Esd Products Inc

Clean Esd Products Inc is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Henry J Austin Health Center

Henry J Austin Health Center is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PolyNovo Limited

At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.

Intervention Services Inc

Intervention Services Inc is a Maitland, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.